2026 NPPES data Pediatrics Physician NPI 1801852025 MD
Verify on CMS →

NANDA BYSANI, MD

Pediatrics Physician in GRAND PRAIRIE, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
8K
Medicare Part D claims · 701 beneficiaries · Pediatrics Physician avg: 762
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

NANDA BYSANI, MD filed 7,796 Medicare Part D claims in 2023 as a Pediatrics Physician in GRAND PRAIRIE, Texas, prescribing 89% generic.

8K
Part D claims, 2023
89%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NANDA BYSANI, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

7,796 Top 3% higher than 97% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

NANDA BYSANI, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NANDA BYSANI, MD?

Quality data not reported

NPI registry status

Active

Issued 04/25/2006

NPI 1801852025

Primary specialty

Pediatrics Physician

High-volume

80,574 US NPIs in this specialty

Medicare Part D claims

7,796 923% vs specialty avg

2023 prescription claims

Specialty avg: 762

Specialty distribution in Texas

How Pediatrics Physician compares to other specialties among Texas providers

Texas providers

Pediatrics Physician share within Texas

1. Pediatrics Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pediatrics Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Pediatrics Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pediatrics Physician ABMS/AOA estimate

Est. board-certified rate (Pediatrics Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pediatrics Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NANDA BYSANI, MD appears in the CMS NPPES registry as a Pediatrics Physician provider holding MD credentials at 710 E PIONEER PKWY, GRAND PRAIRIE, TX, 75051, with a listed phone of (972) 262-8211. NPI 1801852025 was issued on 04/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BYSANI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 7,796 prescription claims written by this provider, covering 701 Medicare beneficiaries and totaling roughly $820K in drug spend, split 11% brand-name and 89% generic by claim count, with an opioid prescribing rate of 1.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pediatrics Physician is a high-volume specialty nationwide, with 80,574 enrolled providers across 56 states and an average of 762 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

710 E PIONEER PKWY
GRAND PRAIRIE, TX 75051

Provider Details

NPI 1801852025
Specialty Pediatrics Physician
Credentials MD
Gender Female
NPI Issued 04/25/2006

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to NANDA BYSANI, MD. To verify NANDA BYSANI, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

NANDA BYSANI, MD — brand share 11.0%
Specialty average (est.)

11% brand-name claims vs 89% generic, on 7,796 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

7,796
Total Claims
$820K
Total Drug Cost
701
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
21,399
Total Day Supply
632,096
Brand vs Generic
11% brand / 89% generic
Brand Drug Cost
$654K
Generic Drug Cost
$161K
Opioid Claims
102 (1.3% rate)
Antibiotic Claims
160

Patient Demographics

Average Patient Age
73.6 years
Avg HCC Risk Score
2.00
Gender Split
60% female / 40% male
Age Distribution
<65: 76, 65-74: 298, 75-84: 250, 85+: 77

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NANDA BYSANI, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
566
Rosuvastatin Calcium
433
Amlodipine Besylate
359
Metformin Hcl
325
Lisinopril
318
Levothyroxine Sodium
299
Gabapentin
189
Losartan Potassium
168
Hydrochlorothiazide
161
Simvastatin
160

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatrics Physician Overview

How NANDA BYSANI, MD fits within the Pediatrics Physician landscape nationally.

80,574
Pediatrics Physician Providers in US
56
States with Pediatrics Physician
762
Avg Claims per Provider

NANDA BYSANI, MD's 7,796 claims are above the specialty average of 762.

Nearby Pediatrics Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as BYSANI.

Compare Pediatrics Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NANDA BYSANI, MD's specialty?
NANDA BYSANI, MD specializes in Pediatrics Physician and practices in GRAND PRAIRIE, Texas. Credentials: MD.
How much does NANDA BYSANI, MD prescribe under Medicare Part D?
In 2023, NANDA BYSANI, MD wrote 7,796 Medicare Part D claims totaling $820K in drug costs for 701 beneficiaries.
Where is NANDA BYSANI, MD located?
NANDA BYSANI, MD is located at 710 E PIONEER PKWY, GRAND PRAIRIE, TX, 75051. Phone: (972) 262-8211.
What is NANDA BYSANI, MD's NPI number?
NANDA BYSANI, MD's National Provider Identifier (NPI) is 1801852025, issued on 04/25/2006.
Does NANDA BYSANI, MD prescribe more brand-name or generic drugs?
NANDA BYSANI, MD's prescribing is 11% brand-name and 89% generic drugs by claim count, with $654K in brand drug costs.
Does NANDA BYSANI, MD prescribe opioids?
Yes, NANDA BYSANI, MD had 102 opioid claims in 2023 with an opioid prescribing rate of 1.3%.
How many Pediatrics Physician providers are there in the US?
There are 80,574 Pediatrics Physician providers across 56 states in the US. The average Pediatrics Physician provider writes 762 Medicare Part D claims per year.
What drugs does NANDA BYSANI, MD prescribe most often?
Based on 2023 Medicare Part D data, NANDA BYSANI, MD's most frequently prescribed drugs include Atorvastatin Calcium, Rosuvastatin Calcium, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NANDA BYSANI, MD accept Medicare?
NANDA BYSANI, MD appears in CMS Medicare data with 7,796 Part D claims and 701 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NANDA BYSANI, MD's credentials?
NANDA BYSANI, MD's NPI is 1801852025 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology